SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-248197
Filing Date
2019-09-18
Accepted
2019-09-18 16:16:03
Documents
7
Period of Report
2019-09-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d795497d8k.htm 8-K 25749
2 EX-1.1 d795497dex11.htm EX-1.1 168391
3 EX-5.1 d795497dex51.htm EX-5.1 9756
4 EX-99.1 d795497dex991.htm EX-99.1 10036
5 GRAPHIC g795497dsp47.jpg GRAPHIC 2634
6 GRAPHIC g795497g20f42.jpg GRAPHIC 2176
7 GRAPHIC g795497g25e68.jpg GRAPHIC 7771
  Complete submission text file 0001193125-19-248197.txt   232931
Mailing Address 29 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 29 HARTWELL AVENUE LEXINGTON MA 02421 617-945-7361
Translate Bio, Inc. (Filer) CIK: 0001693415 (see all company filings)

IRS No.: 611807780 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38550 | Film No.: 191099918
SIC: 2836 Biological Products, (No Diagnostic Substances)